Article info
Commentary
Yours, mine, or ours: cautions about LRT
- Correspondence to Dr Wendy Elizabeth Bonython, School of Law and Justice, Faculty of Business Government and Law, University of Canberra, ACT 2601, Australia; wendy.bonython{at}canberra.edu.au
Citation
Yours, mine, or ours: cautions about LRT
Publication history
- Received July 18, 2017
- Accepted July 20, 2017
- First published August 18, 2017.
Online issue publication
October 25, 2018
Article Versions
- Previous version (18 August 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- ‘There is a lot of good in knowing, but there is also a lot of downs’: public views on ethical considerations in population genomic screening
- Direct to consumer genetic testing and the libertarian right to test
- Cancer patients’ views and understanding of genome sequencing: a qualitative study
- Personal utility in genomic testing: is there such a thing?
- The 100 000 Genomes Project: bringing whole genome sequencing to the NHS
- Prenatal diagnosis of chromosomal imbalances
- Sport and exercise genomics: the FIMS 2019 consensus statement update
- Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist
- Republished review: Next generation sequencing for clinical diagnostics and personalised medicine: implications for the next generation cardiologist
- Whole-genome sequencing